Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens (GINECO)

Publication | Open Access

DOI Full Paper Access

Citations

References

2011

Year

Alain Lortholary, R. Largillier, B. Weber, Laurence Gladieff, J. Alexandre, Xavier Durando, B. Slama, Jérôme Dauba, D. Paraïso, Éric Pujade-Lauraine

Annals of Oncology

Resistant Ovarian CancerOncologyWeekly TopotecanMedicineGynecologyWeekly PaclitaxelPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyGynecology OncologyOvarian Cancer